What is the RX.V share price today?

This page shows the latest available BioSyent Inc. (RX.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is BioSyent Inc. listed?

BioSyent Inc. trades on the TSX Venture Exchange under the symbol RX.V, ISIN CA0906901081.

How large is BioSyent Inc.?

Its market capitalisation is approximately 179.12M CAD, based on the latest available price and share count from our data provider.

TSX Venture Exchange (TSXV) · RX.V · ISIN CA0906901081

BioSyent Inc.

15.73 CAD

−0.33(−2.05%)

Previous close · Sep 18, 13:34 ET

Data last updated: Sep 18, 13:34 ET (20 h ago)· Delayed exchange data

BioSyent Inc. (RX.V) trades on the TSX Venture Exchange and operates in the Medical - Pharmaceuticals industry. Its market capitalisation is approximately 179.12M CAD. The company reports around 60 employees. Its ISIN is CA0906901081. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

TSX Venture Exchange (TSXV)

ISIN

CA0906901081

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

Market cap

179.92M CAD

Employees

Previous close

16.06 CAD

Day range

15.73 – 16.18

52-week range

10.65 – 16.25

Volume

427

50-day average

15.20 CAD

200-day average

14.32 CAD

Asset type

Equity

About BioSyent Inc.

BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. BioSyent Inc. was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. The company was incorporated in 2006 and is headquartered in Mississauga, Canada.

Company website

Frequently asked

What is the RX.V share price today?: This page shows the latest available BioSyent Inc. (RX.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is BioSyent Inc. listed?: BioSyent Inc. trades on the TSX Venture Exchange under the symbol RX.V, ISIN CA0906901081.
How large is BioSyent Inc.?: Its market capitalisation is approximately 179.12M CAD, based on the latest available price and share count from our data provider.

All BioSyent Inc. data comes from exchange and provider feeds for the TSX Venture Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.